Purpose: This scholarly project developed a depression follow-up protocol for use by depression care managers in a military primary care clinic. Additionally, this project evaluated the impact of the protocol on HEDIS antidepressant medication measurements (AMM).
health concerns and costs of depression among U.S. adults. The disorder is associated with excess resource utilization; an estimated $8,000 per year per patient. Murray and Lopez (1997) and WHO (2016) also predict that depression will increase from fourth to second place in contributing to the overall global burden of disease by 2020.
Antidepressant medication and widespread combination psychotherapy has dramatically changed the disease trajectory and well-being of people living with depression. Antidepressant use for the treatment of depression has grown dramatically over the past 15 years; however, the quality of antidepressant treatment has failed to improve, particularly in primary care (Heise & van Servellen, 2013; Katon, 2010) . Comparatively, McManus, Meltzer, Brugha, Bebbington, and Jenkins (2009) reported that the rates of antidepressant medication adherence were particularly low in primary care, where 90% -95% of depression cases are managed. Despite consensus on the value of a collaborative model, this approach has not been the norm (Simon et al., 2011; Solberg, Trangle, & Wineman, 2005) . Relapse has been common and the risk of developing more chronic forms of depression has increased. Considering the prevalence, complication, and cost to the healthcare system, the implementation of a collaborative-care approach to depression management with emphasis on proactive treatment and follow-up in primary care could improve treatment adherence as well as prevent relapses and serious complications.
One of the most widely used sets of healthcare data-performance measured in the United States is the Healthcare Effectiveness Data and Information Set (HEDIS). HEDIS measures have been useful in promoting population health for wide-ranging chronic disorders.
Conversely, other measures, such as those for Antidepressant Medication Management (AMM), have been less successful. Current HEDIS data suggests considerable opportunities for improvement in the quality of mental health services (National Committee Quality Assurance Managed Behavioral Healthcare Organization Accreditation, 2014).
SIGNIFICANCE & AIMS
At the primary care military facility where this project was implemented, frequency and continuity of follow-up care often lacked minimal recommendations. Analysis of primary care antidepressant HEDIS data demonstrated rates well below the HEDIS benchmark. Despite the organization's ongoing efforts to improve antidepressant data scores, their score (43%) was lower than the average (72%) for other major military healthcare facilities. The data suggested that significant number of patients began antidepressant in primary care but did not make any follow-up appointments or refill their prescriptions. Therefore, a telephone follow-up management strategy to improve antidepressant HEDIS measure was considered to address these gaps. Reliance on live contacts during periods of staff shortages made such programs less available and less timely with additional expense. For instance, patients needed to receive a call when nursing staff was available, repeated missed contacts were the norm, with approximately one-half of the attempts being unsuccessful, and each contact required up to 45 minutes of clinician time. Furthermore, there was an absence of a standardized protocol to guide the delivery of the follow-up contact by the staff.
In an attempt to improve depression outcome and the quality of depression care delivered in the primary care clinic, this evidence-based practice (EBP) project aimed to implement best practices in response to the question: In primary care where adult patients are prescribed
antidepressant therapy, what is the effect of a structured protocol integrating depression screening and patient education to guide secure e-mail, as compared to the present practice of no protocol in improving depression outcomes?
LITERATURE REVIEW

Introduction to the Evidence
The evidence for the project was found using the following information sources:
PubMed, Cochrane, PsycInfo, and Psychotherpy.net. Searches were restricted to systematic reviews, meta-analyses, randomized controlled trials, and observational studies from January 2005 to February 2015. Articles were identified by combining terms treatment and depression in both MeSH terms and text words. Additionally, these terms were paired with primary care, HEDIS, best practices, internet or computer or tele-health or online. Furthermore, the search was limited to adults over 18 years old and restricted to studies within the last 10 years. The evidence was reviewed for discussions on follow-up strategies to improve depression outcome.
Next, the evidence presented different elements of successful collaborative care strategies, including telephone and e-mail follow-up interventions. Lastly were the meta-analyses of a collaborative-care-based intervention in the treatment of depression. Evidence was arranged in a sequential order by date. Wagner et al. (2016) and Heise and van Servellen (2013) reported that proactive followup significantly lowered depression severity. Similarly, Richards et al. (2013) revealed that appropriate, reliable follow-up was highly correlated with improved response and remission scores. As cited in an Agency for Healthcare Research and Quality (AHRQ; 2014) study, one point often overlooked was that the depressed patient's pessimism, low motivation, low energy, and sense of isolation and guilt might lead to nonadherence with treatment. Therefore, successful care of major depression required active engagement of each patient plus ongoing education beginning at the time of diagnosis. A study by Katon et al. (1996) uncovered that improved attitudes towards antidepressant medications along with the patient's ability to handle medication side effects were key factors in promoting greater adherence and maintenance treatment, thus greater likelihood of preventing relapse. Several studies (Heise & van Servellen, 2013; Unutzer & Park, 2012) cited the PHQ-9 as a questionnaire useful for follow-up and wellvalidated for assessing diagnosis, severity, outcomes, and monitor progress over time.
The Evidence
A randomized control trial conducted by Wagner et al. (2016) utilized two models to facilitate depression care delivered by providers. One utilized a structured protocol; another relied on clinical acumen in 10 HIV clinics. The two models were compared based on (a) the proportion of all patient participants to those clinically depressed, based on a follow-up PHQ-9 and (b) the proportion of clinically depressed patients who were prescribed antidepressant therapy. Findings confirmed that those in the structured protocol were significantly more likely to received further evaluation by the provider utilizing the PHQ-9 (84% vs. 49%; p = .01). These results suggested that a structured protocol model could be advantageous for ensuring that positively-screened clients received depression evaluation. Richards et al. (2013) conducted a randomized control trial to test the clinical effectiveness of collaborative care with usual care in the management of patients with moderateto-severe depression. Collaborative care intervention included depression education, drug management, behavioral activation, relapse prevention, and primary care liaisons delivered by depression care managers. Furthermore, collaborative care involved 6 to 12 contacts with participants over 14 weeks supervised by a mental health specialist. The primary outcome was the depression symptoms score (PHQ-9), anxiety score (generalized anxiety disorder 7; GAD-7), and quality of life (short 36 questionnaire; SF-36). The collaborative care group comprised 276 participants and 305 participants were allocated to usual care group. Results indicated that quality of mental health was significantly better in collaborative care group than the usual care group and patients were significantly more satisfied. At 4 months, the mean depression score was 11.1 (SD = 7.3) for collaborative care group and 12.7 (SD = 6.8) for usual care group. After adjustment for baseline depression, the mean depression score was 1.33 PHQ-9 points lower (95% CI [0.35, 2.31], p < .01) for participants receiving collaborative care than in those receiving usual care. Collaborative care participants had persistent, positive effects up to 12 months after initiation of the intervention and was preferred by patients over usual care. Simon et al. (2011) conducted a randomized controlled trial comparing typical primary care treatment for depression to primary care supported by online care management. The primary outcomes were the score on the Depression Symptom Checklist Scale and patient satisfaction with care. Secondary outcomes (i.e., antidepressant adherence, use of health record services) were assessed using computerized medical records. Nine primary care clinics enrolled 208 patients beginning antidepressant therapy. Online care management contacts with a trained psychiatric nurse included a structured assessment, algorithm-based feedback to the patient and treating physician, and as-needed facilitation of follow-up care.
Groups were similar in baseline characteristics. The primary outcome demonstrated that patients offered the online program had higher rates of antidepressant adherence (81% vs. 61% continued treatment > 3 months, p = 0.001), lower symptoms checklist depression scores after 5 months (0.95 vs. 1.17, p = 0.043), and greater satisfaction with depression treatment (53% vs.
33% very satisfied, p = 0.004; Simon et al., 2011) . Although the study results suggested greater treatment adherence, there were limitations to the study. While the study evaluated two treatment delivery methods, the results applied only to patients utilizing online messaging.
In a meta-analysis, Krebs et al. (2010) 
NEED FOR PRACTICE CHANGE PROJECT
HEDIS is a set of quality indicators that the Military Health System Population Health Portal (MHSPHP) uses to benchmark performance metrics in their medical treatment facilities.
Quality indicators for HEDIS Antidepressant Medication Management measures focus on compliance with medication regimens and appropriate follow-up as the key to improved depression care. At the military primary care facility where this project was implemented, a significant number of patients beginning antidepressant in the primary care clinic do not make any follow-up appointments or refill their prescriptions. Therefore, frequency and continuity of follow-up care often fall short of minimal guideline recommendations. In fact, analyses of primary care antidepressant data showed rates well below the HEDIS benchmark. management strategy has been implemented to address these gaps. However, follow-up calls did not include the monitoring of depression severity, a repeat of the PHQ-9 at each contact or at least every 3 to 6 months, and progress on the patient's self-management or treatment plan.
Additionally, the challenge with that standard of care involved the lack of consistent staff assignments to provide the follow-up care. This made follow-up care less available, less timely, and more expensive. For instance, patients received calls only when nursing staff would be available; repeated, missed contacts were the norm. Each contact required up to 1 hour of clinician time, one-half of that time was spent on unsuccessful attempts. In an attempt to improve depression outcome and the quality of depression care delivered in the primary care clinic, this EBP quality improvement project aimed to implement best practices in response to the PICO question below.
PICO
In a primary care setting where adult patients are prescribed antidepressant therapy, what is the effect of secure e-mail and telephone follow-up utilizing a nurse-guided depression followup protocol, as compared to usual follow-up monitoring without the protocol. Parallel to the EBP models, it was important to consider nursing theories in the utilization 
MODEL-THEORY
METHODS
Overview
This EBP project was based upon literature supporting an organized approach to patient follow-up by systematically contacting patients by phone, e-mail, or in person to provide specific interventions, facilitate treatment adherence, and monitor symptoms or adverse effects. The EBP goal was to evaluate whether the implementation of follow-up monitoring by secure e-mail and telephone utilizing a systematic nurse-guided approach would increase the outcome of care, improved depression symptoms over three months, as well as HEDIS scores.
Sample and Participants
Thirty-four patients identified from the aggregate primary care clinic provided an adequate sample for the EBP project based on the following inclusion/exclusion criteria. 
Change Process Intervention
The follow-up monitoring protocol was implemented on June 1, 2016. The protocol included a flow chart guiding scheduled patient follow-up by telephone or e-mail. A list of eligible patients was forwarded to the assigned clinic nurse. Each patient was immediately enrolled to the hospital electronic health e-mail communication database and received a welcome message from the depression care manager describing the follow-up protocol. The follow-up secure e-mail contacts were scheduled and initiated by the clinic nurse within two weeks of antidepressant prescription.
Each monitoring contact began with an outreach message from the nurse containing to an online assessment, including the current use of antidepressant, side effects, severity of symptoms, self-care, education, and care support. The assessment also included the PHQ depression questionnaire every two weeks. Those not responding were sent three reminders. A follow-up procedure was developed to standardize the phone calls and e-mail contacts and ensure antidepressant efficacy, safety, and adherence. Completed follow-up encounters were documented in the EMR using a standardized template and forwarded to the primary care prescribing provider.
Data Collection
Pre-identified antidepressant HEDIS data were extracted from the Command's Business
Report portal comprising of the score for the antidepressant HEDIS indicator, performance percentile, and target score to reach respective benchmarks for three fiscal years (i.e., 2013, 2014, 2015) prior to implementing the EBP project in 2016. This data was specific for HEDIS antidepressant, effective, acute-phase treatment (i.e., adults who remained on antidepressant medication for at least 84 days/12 weeks) and continuation phase treatment (i.e., adults who remained on antidepressant medication for at least 180 days/6 months). For the acute phase of treatment, the March 2015 HEDIS scores were 47%; the March 2016 HEDIS data scores were 52%, and the national average was 74% (NCQA, 2014).
Retrospective baseline HEDIS data from the primary care clinic site were collected from the previous 12 months and evaluated to determine if there was a need for the practice change.
The EBP project obtained approval from the Naval Medical Center San Diego and the University of San Diego Institutional Review Boards, and was conducted in compliance with all applicable federal regulations governing protection of human subjects in research (CIP# NMCSD. #2016.0044 and CPI#USD.2016-06-241).
Data Analysis
Data analysis employed quantitative, statistical process control. Control charts with 12 monthly data points allowed for the identification of variation in the data. A patient survey in August 2015 assisted in analyzing the factors for non-compliance of medication adherence and follow-up from the patients' perspective. These findings further demonstrated the need for this EBP quality improvement project.
Following a six month follow-up trial period according to the new protocol, the pre-and post-data was analyzed to determine if the project intervention outcomes demonstrated improvement in the facility HEDIS scores.
The primary goals were to achieve a 10% increase in the HEDIS effective acute phase treatment and a 10% increase in HEDIS effective continuation phase treatment. HEDIS data were tracked prior to project implementation, three months after implementation, and six months post implementation. Figure 2 and 3, the results were positive. The benchmark targeted to improve HEDIS antidepressant scores by 10% was met for the continuation phase. The benchmark targeted to improve HEDIS antidepressant scores by 10% was not met for the acute phase. However, there was an improvement from baseline scores and an increased by 4%. Tables 1   and 2 . Table 1 Cost Avoidance
RESULTS
As demonstrated in
Cost of Depression Treatment
• The average depression treatment = $160/hour
• Treatment failure due to non-adherence to antidepressant medication = $3,480 annually per patient ($160/hr. X 2 one hour treatment session per month = $320 X 12 months/yr. = $3,840)
• Currently 227 patients are enrolled to the clinics are receiving care for depression ($3,840 X 227 patients = $871,680
Note. Adapted from "Treatment costs of Depression," by Depression D. Retrieved from http://depressiond.org/treatment-costs-of-depression/ Table 2 Cost Benefit The small number of subjects limited the power to detect to differences in HEDIS scores for the entire command.
COST BENEFIT
Project Cost
DISCUSSION
The recommendations regarding treatment and ongoing management for depression 
CONCLUSION
One feasible method of improving depression care can be accomplished by utilizing a mental health nurse to supplement the primary care clinician in-office intervention with greater attention on providing a systematic, multimodal approach to follow-up and follow-through of patients. Six months after implementation, the structured, multimodal, secure e-mail follow-up protocol was associated with improvement in patient outcome and HEDIS antidepressant measurements for the primary care clinic. Furthermore, the project was associated with a high degree of patient satisfaction. Given the plethora of evidence to support this approach together with the positive and substantial cost benefit, evidence suggests facilitating this program throughout the command in order to approach the top decile (90th percentile) HEDIS antidepressant national benchmark for Naval Hospital Camp Pendleton.
